Pharmacodynamics
Betamethasone acts because of its structural similarity to endogenous glucocorticoids. Unbound, it can penetrate the membrane of the cell and then bind with high affinity to intracellular glucocorticoid receptors.
The anti-inflammatory (anti-inflammatory) effect is achieved by interfering with the so-called arachidonic acid metabolism. Betamethasone causes fewer prostaglandins and leukotrienes to be produced at the end of this metabolism. These are significantly involved in the inflammatory process of the human body.
Betamethasone has an anti-allergic effect by preventing the release of histamine and simultaneously reducing the number and activity of certain B and T lymphocytes.
Pharmacokinetics
The absorption and potency of betamethasone is highly dependent on the salt used. By attaching a specific salt, certain properties such as solubility and rate of absorption can be controlled. The metabolism of betamethasone yields 6 metabolites. Metabolic processes include 6β-hydroxylation, 11β-hydroxyl oxidation, and reduction of the C-20 carbonyl group followed by removal of the side chain. Corticosteroids are predominantly excreted in the urine. The half-life of betamethasone is about 10-12 hours.